Miss Rate of Gastric Neoplasms Under Computer-aided Endoscopy
Recruiting
N/A
Interventional Study
Gastric Neoplasm
Artificial Intelligence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 1,000 (estimated)
- Sponsor
- The University of Hong Kong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective randomized trial compares AI-assisted upper gastrointestinal endoscopy with high definition upper gastrointestinal endoscopy in term of missed rate of gastric neoplasm. The investigators hypothesize the miss rate of high definition upper gastrointestinal endoscopy is higher than AI-assisted upper gastrointestinal endoscopy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged 40 or older
* Scheduled for elective upper endoscopy
Exclusion Criteria:
* Pregnant women,
* Inability to provide written informed consent
* Prior gastrectomy, and
* Patients deemed unsuitable or high-risk for endoscopy with severe comorbid illnesses
Contacts